» Articles » PMID: 26758274

Crystal Structure of the N-myristoylated Lipopeptide-bound MHC Class I Complex

Overview
Journal Nat Commun
Specialty Biology
Date 2016 Jan 14
PMID 26758274
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The covalent conjugation of a 14-carbon saturated fatty acid (myristic acid) to the amino-terminal glycine residue is critical for some viral proteins to function. This protein lipidation modification, termed N-myristoylation, is targeted by host cytotoxic T lymphocytes (CTLs) that specifically recognize N-myristoylated short peptides; however, the molecular mechanisms underlying lipopeptide antigen (Ag) presentation remain elusive. Here we show that a primate major histocompatibility complex (MHC) class I-encoded protein is capable of binding N-myristoylated 5-mer peptides and presenting them to specific CTLs. A high-resolution X-ray crystallographic analysis of the MHC class I:lipopeptide complex reveals an Ag-binding groove that is elaborately constructed to bind N-myristoylated short peptides rather than prototypic 9-mer peptides. The identification of lipopeptide-specific, MHC class I-restricted CTLs indicates that the widely accepted concept of MHC class I-mediated presentation of long peptides to CTLs may need some modifications to incorporate a novel MHC class I function of lipopeptide Ag presentation.

Citing Articles

Antigen presentation of post-translationally modified peptides in major histocompatibility complexes.

de Wit A, Bianchi F, van den Bogaart G Immunol Cell Biol. 2024; 103(2):161-177.

PMID: 39609891 PMC: 11792782. DOI: 10.1111/imcb.12839.


Opening opportunities for K determination and screening of MHC peptide complexes.

Kopicki J, Saikia A, Niebling S, Gunther C, Anjanappa R, Garcia-Alai M Commun Biol. 2022; 5(1):488.

PMID: 35606511 PMC: 9127112. DOI: 10.1038/s42003-022-03366-0.


Crystal structures of lysophospholipid-bound MHC class I molecules.

Shima Y, Morita D, Mizutani T, Mori N, Mikami B, Sugita M J Biol Chem. 2020; 295(20):6983-6991.

PMID: 32269076 PMC: 7242709. DOI: 10.1074/jbc.RA119.011932.


A review of lipidation in the development of advanced protein and peptide therapeutics.

Menacho-Melgar R, Decker J, Hennigan J, Lynch M J Control Release. 2018; 295:1-12.

PMID: 30579981 PMC: 7520907. DOI: 10.1016/j.jconrel.2018.12.032.


Neutrophils and the S100A9 protein critically regulate granuloma formation.

Yoshioka Y, Mizutani T, Mizuta S, Miyamoto A, Murata S, Ano T Blood Adv. 2018; 1(3):184-192.

PMID: 29296934 PMC: 5737174. DOI: 10.1182/bloodadvances.2016000497.


References
1.
Shastri N, Schwab S, Serwold T . Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol. 2002; 20:463-93. DOI: 10.1146/annurev.immunol.20.100301.064819. View

2.
Maurer-Stroh S, Eisenhaber B, Eisenhaber F . N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences. J Mol Biol. 2002; 317(4):523-40. DOI: 10.1006/jmbi.2002.5425. View

3.
Hulsmeyer M, Hillig R, Volz A, Ruhl M, Schroder W, Saenger W . HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J Biol Chem. 2002; 277(49):47844-53. DOI: 10.1074/jbc.M206392200. View

4.
Peterlin B, Trono D . Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol. 2003; 3(2):97-107. DOI: 10.1038/nri998. View

5.
Boulter J, Glick M, Todorov P, Baston E, Sami M, Rizkallah P . Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 2003; 16(9):707-11. DOI: 10.1093/protein/gzg087. View